1. a. A pharmacist may, pursuant to statewide protocols developed by the board in consultation with the department of public health and consistent with subsection 2, order and administer the following to patients ages eighteen years and older:

 (1) Naloxone.
 (2) Nicotine replacement tobacco cessation products.
 (3) An immunization or vaccination recommended by the United States centers for disease control and prevention advisory committee on immunization practices in its approved vaccination schedule for adults.
 (4) An immunization or vaccination recommended by the United States centers for disease control and prevention for international travel.
 (5) A Tdap (tetanus, diphtheria, acellular pertussis) vaccination in a booster application.
 (6) Other emergency immunizations or vaccinations in response to a public health emergency.
 (7) An immunization or vaccination for COVID-19 as defined in section 686D.2.
 b. A pharmacist may, pursuant to statewide protocols developed by the board in consultation with the department of public health and consistent with subsection 2, order and administer the following to patients ages six months and older:

 (1) A vaccine or immunization for influenza.
 (2) Other emergency immunizations or vaccines in response to a public health emergency.
 c. A pharmacist may, pursuant to statewide protocols developed by the board in consultation with the department of public health and consistent with subsection 2, order and administer the final two doses in a course of vaccinations for HPV to patients ages eleven years and older.
 d. Prior to the ordering and administration of a vaccination or immunization authorized by this subsection, pursuant to statewide protocols, a licensed pharmacist shall consult and review the statewide immunization registry or health information network. The board shall adopt rules requiring the reporting of the administration of vaccines and immunizations authorized by this subsection to a patient’s primary health care provider, primary physician, and a statewide immunization registry or health information network.
 e. A pharmacist may, pursuant to statewide protocols developed by the board in consultation with the department of public health and consistent with subsection 2, order and administer the following to patients ages six years and older:

 (1) Point-of-care testing and treatment for influenza, streptococcus A, and COVID-19 as defined in section 686D.2 at the point of interaction between a pharmacist and a patient.
 (2) Point-of-care testing at the point of interaction between a pharmacist and a patient in response to a public health emergency.

Terms Used In Iowa Code 155A.46

  • Administer: means the direct application of a prescription drug, whether by injection, inhalation, ingestion, or any other means, to the body of a patient or research subject by one of the following:
     a. See Iowa Code 155A.3
  • Board: means the board of pharmacy. See Iowa Code 155A.3
  • Department: means the Iowa department of public health. See Iowa Code 154A.1
  • drug: means a drug, as classified by the United States food and drug administration, that is required by the United States food and drug administration to be prescribed or administered to a patient by a practitioner prior to dispensation. See Iowa Code 155A.3
  • following: when used by way of reference to a chapter or other part of a statute mean the next preceding or next following chapter or other part. See Iowa Code 4.1
  • Pharmacist: means a person licensed by the board to practice pharmacy. See Iowa Code 155A.3
  • Pharmacy: means a location where prescription drugs are compounded, dispensed, or sold by a pharmacist and where prescription drug orders are received or processed in accordance with the pharmacy laws. See Iowa Code 155A.3
  • Product: means the same as defined in 21 U. See Iowa Code 155A.3
  • United States: includes all the states. See Iowa Code 4.1
 2. A pharmacist ordering or administering a prescription drug, product, test, or treatment pursuant to subsection 1 shall do all of the following:

 a. Maintain a record of all prescription drugs, products, tests, and treatments administered pursuant to this section.
 b. Notify the patient’s primary health care provider of any prescription drugs, products, tests, or treatments administered to the patient, or enter such information in a patient record system also used by the primary health care provider, as permitted by the primary health care provider. If the patient does not have a primary health care provider, the pharmacist shall provide the patient with a written record of the prescription drugs, products, tests, or treatment provided to the patient and shall advise the patient to consult a physician.
 c. Complete continuing pharmacy education related to statewide protocols recognized and approved by the board.
  Previous section
Next section  
 Chapter 155A Contents